L-α-Aminoadipic Acid
(Synonyms: L-2-氨基己二酸,(S)-2-Aminohexanedioic Acid) 目录号 : GC13740
L-α-Aminoadipic Acid是一种具有神经兴奋特性的赖氨酸代谢物，可竞争性抑制谷氨酸转运蛋白，Ki值为192μM。
Cas No.:1118-90-7
Sample solution is provided at 25 µL, 10mM.
L-α-Aminoadipic Acid is a lysine metabolite with neuroexcitatory properties, which competitively inhibits glutamate transporters with a Ki value of 192µM[1,2]. L-α-Aminoadipic Acid is one of the isomeric forms of 2-Aminoadipic acid and is crucial for neurotransmitter regulation and glutamate transport inhibition[3]. L-α-Aminoadipic Acid is commonly used in research to selectively inhibit astrocyte function for investigating their physiological and pathological roles, and also serves as a precursor for β-lactam antibiotics in the development of novel antibiotics[4,5].
In vitro, treatment of mouse cerebellar cells with L-α-Aminoadipic Acid (0.34mM) for 2h induced reversible swelling in approximately 80% of astrocytes; prolonged treatment for 40h resulted in the death of 97% of astrocytes[6]. In rat amygdala slices, treatment with L-α-Aminoadipic Acid (1mM) for ≥90min increased the nuclear area of glial fibrillary acidic protein (GFAP)-positive astrocytes and significantly reduced the N-methyl-D-aspartate receptor (NMDAR)-mediated excitatory postsynaptic currents (EPSCs) evoked by strong stimulation in the thalamo-LA pathway[7].
In vivo, intravitreal injection of L-α-Aminoadipic Acid (8µM/eye; 50µL) in carp led to a reduction in S-potentials and a relatively lower resting potential in retinal horizontal cells within 2-4h; the voltage characteristics of horizontal cells returned to normal within 1-2 days[8]. In adult male Wistar rats, bilateral microinjection of L-α-Aminoadipic Acid (25µg/µL/day; 1µL/rat (0.5µL per side)) into the hippocampal CA1 region for 3 days significantly reduced the number of GFAP-immunoreactive (GFAP-ir) astrocytes in the hippocampus, resulting in impaired passive avoidance memory and increased anxiety-like behavior[9].
References:
[1] WU H Q, UNGERSTEDT U, SCHWARCZ R. l-α-Aminoadipic acid as a regulator of kynurenic acid production in the hippocampus: a microdialysis study in freely moving rats[J]. European journal of pharmacology, 1995, 281(1): 55-61.
[2] MCBEAN G J. Inhibition of the glutamate transporter and glial enzymes in rat striatum by the gliotoxin, alpha aminoadipate[J]. British journal of pharmacology, 1994, 113(2): 536.
[3] SHI W, YANG Z, FU P, et al. Metabolite 2-aminoadipic acid: implications for metabolic disorders and therapeutic opportunities[J]. Frontiers in Pharmacology, 2025, 16: 1569020.
[4] ISOBE K, TOKUTA K, NARITA Y, et al. Production of Nα-benzyloxycarbonyl-L-aminoadipic acid and Nα-benzyloxycarbonyl-D-aminoadipic acid with Rhodococcus sp. AIU Z-35-1[J]. Journal of Molecular Catalysis B: Enzymatic, 2004, 32(1/2): 27-32.
[5] GUIDETTI P, SCHWARCZ R. Determination of α-aminoadipic acid in brain, peripheral tissues, and body fluids using GC/MS with negative chemical ionization[J]. Molecular brain research, 2003, 118(1/2): 132-139.
[6] HUCK S, GRASS F, HATTEN M E. Gliotoxic effects of α-aminoadipic acid on monolayer cultures of dissociated postnatal mouse cerebellum[J]. Neuroscience, 1984, 12(3): 783-791.
[7] LI Y, SACCHI S, POLLEGIONI L, et al. Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level[J]. Nature communications, 2013, 4(1): 1760.
[8] SUGAWARA K, TORIGOE K, OKOYAMA S, et al. Neurotoxic effects of l-α-aminoadipic acid on the carp retina: a long term observation[J]. Neuroscience, 1990, 36(1): 155-163.
[9] JAHANSHAHI M, ELYASI L, NIKMAHZAR E. L-α-aminoadipic Acid-Induced Astrocytes Inhibition in the Hippocampal CA1 Region Leads to Anxiety-like Behavior and Memory Impairment[J]. Basic and Clinical Neuroscience, 2025, 16(1).
L-α-Aminoadipic Acid是一种具有神经兴奋特性的赖氨酸代谢物，可竞争性抑制谷氨酸转运蛋白，Ki值为192μM[1,2]。L-α-Aminoadipic Acid是2-Aminoadipic acid的其中一种异构体形式，对神经递质调节和谷氨酸转运抑制至关重要[3]。L-α-Aminoadipic Acid通常用于靶向抑制星形胶质细胞功能以探究其生理与病理作用的研究，也作为β-内酰胺类抗生素的前体用于新型抗生素的开发[4,5]。
在体外，L-α-Aminoadipic Acid（0.34mM）处理小鼠小脑细胞2h，引起约80%的星形胶质细胞出现可逆性肿胀；若持续处理40h，则导致97%的星形胶质细胞死亡[6]。L-α-Aminoadipic Acid（1mM）处理大鼠杏仁核切片≥90min，引起神经胶质纤维酸性蛋白（GFAP）阳性的星形胶质细胞核面积增大，并显著降低了由强刺激诱发的thalamo-LA通路中N-甲基-D-天门冬氨酸受体（NMDAR）介导的兴奋性突触后电流（EPSC）[7]。
在体内，L-α-Aminoadipic Acid（8μM/eye; 50μL）通过眼内注射处理鲤鱼，2-4h后视网膜水平细胞的S电位降低且静息电位相对较低，1-2天后水平细胞的电压特征恢复正常[8]。L-α-Aminoadipic Acid（25μg/μL/day; 1μL/rat (0.5μL on each side)）通过双侧海马CA1区微量注射处理成年雄性Wistar大鼠3天，显著降低了海马体中GFAP-immunoreactive（GFAP-ir）星形胶质细胞的数量，并导致被动回避记忆受损和焦虑样行为增加[9]。
| Cell experiment [1]: | |
Cell lines | Postnatal mouse cerebellum |
Preparation Method | Cells dissociated from early postnatal mouse cerebellum were maintained in vitro for 4 days and then exposed to L-α-Aminoadipic Acid (0.34mM; 40h), then cultures grown on poly-D-lysine coated glass coverslips were subjected to immunohistochemistry. |
Reaction Conditions | 0.34mM; 40h |
Applications | After a 2h exposure to 0.34mM L-α-Aminoadipic Acid, approximately 80% of the astrocytes with characteristic nuclear and cytoplasmic swelling recovered, whereas after a 40h exposure, the same concentration killed 97% of the astrocytes. |
| Animal experiment [2]: | |
Animal models | Adult male Wistar rats |
Preparation Method | Experimental group (L-α-Aminoadipic Acid), with stereotaxic surgery, received L-α-Aminoadipic Acid at dose of 25μg/μL once daily (1μL/rat (0.5μL on each side) of L-α-Aminoadipic Acid were injected into the CA1 hippocampal area by a Hamilton micro-syringe over one minute) for three consecutive days and evaluated for behavioral test. The number of GFAP-ir astrocytes was counted in a 30000μm2 area at three regions (CA1, CA3, and DG regions) of the hippocampus by the cellSens standard 1.14 software. |
Dosage form | 25μg/μL/day; 1μL/rat (0.5μL on each side); 3 days; intrahippocampal injection |
Applications | Microinjection of L-α-Aminoadipic Acid into the CA1 subfield of the hippocampus significantly decreased the step-through latency time in the passive avoidance test, decreased time spent in the open arm, and increased time spent in the closed arm in the elevated plus maze test. Also, the administration of L-α-Aminoadipic Acid significantly declined the density of GFAP-ir astrocytes in the hippocampus. |
References: | |
| Cas No. | 1118-90-7 | SDF | |
| 别名 | L-2-氨基己二酸,(S)-2-Aminohexanedioic Acid | ||
| 化学名 | 2S-amino-hexanedioic acid | ||
| Canonical SMILES | OC(CCC[C@H](N)C(O)=O)=O | ||
| 分子式 | C6H11NO4 | 分子量 | 161.2 |
| 溶解度 | ≤10mg/ml in 1N HCl;0.5mg/ml in PBS | 储存条件 | Store at -20°C,protect from light |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 6.2035 mL | 31.0174 mL | 62.0347 mL |
| 5 mM | 1.2407 mL | 6.2035 mL | 12.4069 mL |
| 10 mM | 620.3 μL | 3.1017 mL | 6.2035 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet